Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

CapVest acquires German generics maker Stada for €10bn

London-based PE firm CapVest has bought a 70% stake in German pharma company Stada, in Europe’s biggest healthcare deal of 2025 so far. Bain Capital and Cinven, the company’s joint PE owners since 2017, will continue to hold the remaining 30%.

Top 5 for-profit laboratory service groups in EMEA 2024

This week’s infographic showcases the top five for-profit diagnostic laboratory service groups in the EMEA region based on their most recent revenue figures. These companies have established themselves as leaders across Europe, the Middle East, and Africa.

Macquarie buys 40% stake in Luz Saude

Infrastructure investor Macquarie has bought a 40% stake in Luz Saude, Portugal’s second largest private hospital group by revenue, for a base consideration of €310 million. The deal values Luz Saude at €1.1 billion in terms of enterprise value, a 9.5x multiple of the group’s 2024 EBITDA.

Boots to be spun off from WBA

US PE firm Sycamore Partners has completed its $10 billion take-private of Walgreens Boots Alliance (WBA), a US healthcare, pharmacy and retail company that owns UK pharmacy chain Boots. Sycamore has decided to separate off Boots, as expected.

Is the profit motive at odds with impact investing goals in emerging market healthcare?

Last week Bloomberg accused US private equity firm TPG of putting profit before the interest of patients in various emerging market hospitals it has invested in. We spoke to TPG to get their response to the specific accusations made against them. We also spoke to others operating in Africa about whether there is, at a more general level, a tension between seeking profit whilst simultaneously seeking to achieve impact investing goals in emerging market healthcare. 

FREE BLOG Partnerships in healthcare

Last week I had the pleasure of making a business trip to Bavaria to spend time with a key long-term business partner. Although like many business trips this was just a brief overnight visit, my colleagues and I did get the chance to walk around the imposing Nuremberg Castle, which dates back to 1140 AD, and through the historical mile which rewards visitors with its enchanting medieval architecture. 

Microsoft launches its AI scribe in the UK

Microsoft is releasing its AI scribe for clinicians, Dragon Copilot, in the UK on Thursday September 4. In a demo with HBI, Dr Simon Wallace, Chief Clinical Information Officer at Microsoft, explained why he believes the product has an edge over the numerous competitors in this space and a good shot at becoming the dominant supplier to the NHS.

Tensions between Indian providers and insurers “likely to continue” in the near term

Long-standing tensions between private Indian healthcare providers and insurers erupted into a major stand-off over the past two weeks. Many North Indian providers unilaterally decided to suspend cashless treatment for people insured by Bajaj Allianz, one of India’s biggest health insurers, because of complaints that claims were not being settled on time. This dispute has now been resolved, but we hear such tensions between providers and payors are a widespread issue in the Indian market and likely to continue in the near term.

Find Us